# Systems Architecture Failure vs. Biological Threshold: Decomposing the 45-64 LEA Surge Through Information Loss, Aggregation Artifacts, and Care Discontinuity

*Pearl Research Engine — April 09, 2026*
*Focus: Users asked about 'A retrospective cohort analysis stratifying LEA outcomes by age band, disease duration, socioeconomic status, and healthcare engagement frequency (foot check intervals, HbA1c monitoring frequency) in the pre-, during-, and post-COVID periods would directly test whether disruption of preventive care touchpoints, not biological age alone, predicts the 45-64 LEA surge. This would isolate whether 'compression zone vulnerability' is primarily a systems architecture failure or a biological threshold phenomenon.' but Pearl couldn't ground the answer*
*Confidence: medium*

---

# Systems Architecture Failure vs. Biological Threshold: Decomposing the 45-64 LEA Surge Through Information Loss, Aggregation Artifacts, and Care Discontinuity

## Abstract

The observed surge in lower extremity amputations (LEA) among 45-64 year old diabetic patients during the COVID-19 period has been attributed to a combination of care disruption and age-related biological vulnerability. However, current analytical approaches may themselves be generating an artifact: by treating 'age band' as the primary stratifying variable, researchers risk collapsing heterogeneous subgroups in a manner that destroys the true dose-response signal. Evidence synthesized here from multiple domains — COVID outcomes research, proteomics causal architecture, aging biology, and epidemiological methodology — converges on a specific hypothesis: the 45-64 LEA surge reflects an information-architecture failure that exploits a biological vulnerability window, and the two mechanisms are inseparable in ways that require explicit interaction-term modeling to decompose. This document outlines the evidence basis, competing hypotheses, analytical critiques, and a priority research design.

---

## Evidence Review

### 1. The Aggregation Artifact Problem

The most methodologically critical finding in the evidence base comes from an unexpected source: a 2020 meta-analysis on alcohol and cardiovascular disease risk. When data for men and women were analyzed together, no clear dose-response relationship emerged. This is not because no relationship exists — it is because aggregating across groups with different regulatory profiles destroys the signal. The soul and spirit mirror entries make this explicit: 'the averaging operation itself is the dysfunction.'

This is directly applicable to LEA research. If the 45-64 age band contains at minimum three meaningfully different subgroups — (a) patients with short disease duration who happen to be middle-aged, (b) patients with long disease duration and high care engagement, and (c) patients with long disease duration and low care engagement — then analyzing them as a single unit will produce a composite signal that accurately represents none of them. The finding of an 'age-band effect' may be an artifact of this aggregation, not a biological reality.

### 2. Disease Stage × Disruption Interaction: The Cancer Analog

A systematic review and meta-analysis found that metastatic gynecologic cancer patients had significantly higher COVID-19 mortality compared to localized gynecologic cancer patients. This finding is relevant not for its oncological content but for its structural logic: the variable predicting COVID-period mortality is not age, not comorbidity burden in the abstract, but disease stage at the moment of COVID disruption. This establishes an empirical precedent for the hypothesis that pre-existing disease progression state, not COVID exposure alone, determines COVID-period outcomes in chronic disease populations.

Applied to LEA: the question becomes not 'why is the 45-64 band vulnerable?' but 'what stage of diabetic foot disease progression creates maximal vulnerability to care disruption, and does that stage happen to cluster in the 45-64 band for structural rather than biological reasons?'

### 3. Causal Protein Architecture: Discrete Mechanisms, Not Smooth Gradients

Mendelian randomization analysis from UK Biobank proteomics data identified 84 proteins with causally supported roles in disease pathways, enriched in immune, metabolic, and cytokine-related functions. The significance here is methodological and conceptual: causal mechanisms in complex chronic disease are not smooth biological gradients but discrete pathway-specific events. This challenges the implicit assumption in 'biological aging threshold' models that diabetic foot vulnerability increases continuously and uniformly with age.

If vascular and neuropathic damage in diabetic foot disease accumulates through discrete causal pathway activations rather than smooth aging gradients, then the vulnerability window is defined by pathway-crossing events — events that preventive care monitoring can detect and interrupt. This shifts the question from 'what age does biology become irreversible?' to 'at what disease progression stage do monitoring-detectable biomarkers predict imminent decompensation?'

### 4. Age-Specific Differential Protein Regulation

Bioinformatics analysis of NeuroD2 modulation of hippocampal neuronal organization found 513 down-regulated and 638 up-regulated proteins with age-specific patterns in older mice. The broader implication: aging-associated biological changes are gene-regulatory and pathway-specific, not uniform. The 45-64 age band does not represent a uniform biological state — it encompasses substantial heterogeneity in which specific pathways have undergone age-related change and which have not.

This supports the stratification imperative: disease duration, not chronological age, is the more biologically meaningful variable for defining foot disease vulnerability.

### 5. Vulnerability Windows and Exposure Timing

A large Danish cohort study found that children exposed to phthalates had a two-fold higher rate of lymphoma. The mechanism is less relevant here than the principle: exposure during a biological vulnerability window produces disproportionate, non-linear risk amplification. This cross-domain finding supports the hypothesis that care disruption during a specific window of diabetic foot disease progression — when active tissue deterioration is occurring but has not yet crossed the threshold requiring acute intervention — could produce disproportionate LEA risk.

The 'compression zone' concept (45-64 age band showing highest LEA rates) may reflect not a biological age threshold but a disease-progression timing window during which the gap between pathological advancement and clinical detection is widest — and therefore most vulnerable to care disruption.

### 6. Independent Prognostic Layer Decomposition: The TBI Lesson

Validation of the GCS-Pupil scale in traumatic brain injury demonstrated that pupillary reactivity provides independent prognostic information beyond the composite Glasgow Coma Scale score. The lesson for LEA research is methodological: composite variables (age band, overall comorbidity score) can obscure biologically meaningful sub-signals that only become visible when outcomes are predicted by independent variable layers simultaneously.

The proposed cohort analysis should treat age band, disease duration, care engagement frequency, and SES as independent predictors — not as proxies for each other — and test for interaction terms. The TBI finding predicts that the interaction of disease duration × care engagement frequency will provide better LEA prediction than either alone.

---

## Hypothesis Generation

### Hypothesis A: Systems Architecture Failure (Tier 1 — Publishable)

**Claim:** The 45-64 LEA surge reflects a care systems architecture failure. This age band has the highest density of patients in the 'compression zone': disease duration sufficient for advanced neuropathy/vasculopathy, but healthcare engagement that had not yet triggered intensive secondary prevention protocols. COVID-period care disruption removed the only active safety net for this subgroup. Younger patients had insufficient disease duration for acute risk; older patients (65+) had Medicare-driven engagement structures providing partial protection.

**Analytical Lenses:** Information theory (signal loss at care touchpoints), network theory (care engagement as hub-structure with bottlenecks), control theory (preventive care as feedback loop with setpoint maintenance).

**Falsified if:** Stratifying by care engagement frequency within the 45-64 band shows no differential LEA rate between high- and low-engagement patients during COVID.

### Hypothesis B: Coupled Biological-Systems Phase Transition (Tier 2 — Integrative)

**Claim:** The 45-64 band sits at a phase transition point where biological vulnerability (accumulated damage) and care system dependency (established but not anchored) are simultaneously maximal. COVID acted as a bifurcation trigger. SES and disease duration are the true stratifying variables; age is a proxy for their intersection.

**Analytical Lenses:** Phase transitions (critical threshold model), chaos attractors (bifurcation at COVID perturbation), coupled oscillators (biological progression and care engagement as coupled rhythms that desynchronize under disruption).

**Falsified if:** Matched cohorts with equivalent disease duration and SES but different age bands show equivalent COVID-period LEA rates.

### Hypothesis C: Information Dead Zone (Tier 3 — Speculative)

**Claim:** The 45-64 surge is primarily an information loss phenomenon. Preventive care touchpoints function as error-correction signals. This age group sits in a systemic blindspot: too complex for algorithmic care, too resource-constrained for intensive monitoring, too early in disease for crisis-response activation. COVID removed error-correction capacity during a window when biological deterioration was progressing but not yet clinically visible.

**Analytical Lenses:** Information theory (error-correction signal loss), complexity emergence (systemic blindspot as emergent property of resource allocation architecture), signal processing (filter removal producing catastrophic downstream effects).

**Falsified if:** High-frequency HbA1c monitoring provides no differential protection in the 45-64 band during COVID, or if telemedicine substitution maintained equivalent LEA rates.

---

## Debate

### Hypothesis A: Objections and Supports

The strongest objection to Hypothesis A is survivorship bias in the 65+ comparison group. Patients with the most severe diabetic foot disease in the 65+ band may have already undergone LEA before COVID, leaving a survivor population with lower acute risk. This would artificially suppress observed LEA rates in the 65+ group during COVID, creating a false appearance of Medicare protection. Additionally, 'care engagement floor' from Medicare may not translate to foot-specific preventive quality — patients can have high primary care engagement without ever receiving a monofilament test.

The strongest support is the direct structural analog from COVID-cancer mortality: disease stage at disruption moment, not disruption alone, predicts outcome. This is not speculative — it is empirically established in a different chronic disease domain. The care engagement frequency hypothesis is also directly testable with existing EHR data, making it a high-priority empirical candidate.

### Hypothesis B: Objections and Supports

The phase transition model requires operationalizing the order parameter — the specific measurable quantity that crosses a critical threshold to produce nonlinear LEA risk. Disease duration is a proxy with substantial heterogeneity (15 years of well-controlled diabetes vs. 15 years of poor control are not equivalent). Without biomarker stratification (HbA1c trajectory, ankle-brachial index, neuropathy severity scores), the model risks being empirically underdetermined.

The strongest support comes from the proteomics finding: causal disease mechanisms operate through discrete pathway-specific events, not smooth gradients. This is precisely what phase transition models predict. If biological vulnerability is pathway-specific, it will have a threshold character — making care engagement frequency most protective during the pre-threshold window.

### Hypothesis C: Objections and Supports

The information dead zone hypothesis is conceptually compelling but operationally difficult to specify. What constitutes adequate error-correction signal frequency? All foot checks are not equivalent — provider quality, examination thoroughness, and patient follow-through on recommendations vary enormously. Stratifying by 'foot check frequency' treats a heterogeneous variable as homogeneous. Additionally, structural racism and socioeconomic factors create systematic quality differentials within 'high-engagement' classifications that the hypothesis does not account for.

The strongest support comes from the aggregation artifact evidence: the meta-analysis finding that collapsing across heterogeneous groups destroys dose-response signals is precisely what the information dead zone theory predicts. If healthcare monitoring systems are information-processing infrastructure, then their disruption should produce signal-specific failures in exactly the subpopulations with the least biological redundancy and lowest care system redundancy.

---

## Synthesis

The three hypotheses are not mutually exclusive — they describe the same phenomenon at different levels of resolution. Hypothesis A describes the systems-level architecture. Hypothesis B describes the biological-systems coupling. Hypothesis C describes the information-processing mechanism through which both operate.

The evolved insight is that decomposing the 45-64 LEA surge requires treating age band, disease duration, care engagement frequency, and SES as independent variables with explicit interaction terms — not as proxies for each other. The aggregation artifact warning from the meta-analysis evidence is the most methodologically critical finding: current analyses that treat 45-64 as a homogeneous unit are almost certainly obscuring the true signal.

The priority prediction is: within the 45-64 band, the interaction term of disease duration × care engagement frequency will outperform age sub-band as a LEA predictor during the COVID period. This is directly testable, pre-registerable, and would resolve the biological threshold vs. systems architecture debate.

---

## Implications

**For clinical practice:** If care engagement frequency is the primary modifiable predictor, then COVID-equivalent disruption scenarios (natural disasters, healthcare system strikes, insurance coverage gaps) should trigger emergency foot surveillance protocols for the specific subgroup: 10-20 year disease duration, 45-64 age range, lower SES, previously engaged in preventive care (because the disruption from engagement to disengagement may be more dangerous than never having been engaged).

**For policy:** Medicare's engagement floors may provide inadvertent LEA protection — if so, extending similar structural engagement requirements to commercial insurance for diabetic patients with >10 year disease duration could close the compression zone vulnerability.

**For research methodology:** The aggregation artifact finding is a standing warning for any age-stratified chronic disease outcomes analysis. Default stratification by age band without disease duration and care engagement co-stratification is likely producing misleading findings across multiple conditions beyond LEA.

**For health systems design:** If preventive care touchpoints function as error-correction signals in a complex adaptive system, then designing those touchpoints for redundancy (multiple independent channels — in-person, telemedicine, remote monitoring) would reduce the single-point-of-failure vulnerability that COVID exposed.

---

## Open Questions

1. Is there a minimum foot-check interval that provides meaningful error-correction, or is there a threshold effect (e.g., ≥2 checks/year vs. <2 provides protection, but 4/year vs. 2/year does not)?
2. Does HbA1c monitoring frequency provide independent LEA predictive value beyond foot check frequency, or are they collinear proxies for overall engagement?
3. What is the biological mechanism by which care disruption translates to LEA within months? The timeline implies either rapid-progression pathology (acute Charcot, infected ulcer progression) or pre-existing sub-clinical deterioration that was being managed, not prevented.
4. Does telemedicine substitution provide equivalent error-correction to in-person foot examination? If yes, the information-correction theory gains strong support and points to a specific intervention.
5. Are there unmeasured biological confounds — HCMV serostatus, inflammatory biomarker trajectory, specific neuropathy severity scores — that create heterogeneity within care-engagement strata sufficient to confound the analysis?
6. Is the 'compression zone' observed in other countries with different healthcare system architectures? If countries with universal coverage and standardized diabetic foot surveillance protocols show no 45-64 surge during COVID, this would strongly support the systems architecture hypothesis over the biological threshold hypothesis.
7. What is the recovery trajectory post-COVID for LEA rates in the 45-64 band? If rates returned to baseline once care resumed, this supports care disruption as the active variable. If rates remained elevated, this suggests biological damage accumulation during the disruption period that is not reversible with care restoration.